HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zhao, Tao ^a,b,c   Zhu, Yuxi ^a,b,d   Morinibu, Akiyo ^a,b   Kobayashi, Minoru ^a,b   Shinomiya, Kazumi ^a,b   Itasaka, Satoshi ^a   Yoshimura, Michio ^a   Guo, Guozheng ^c   Hiraoka, Masahiro ^a   Harada, Hiroshi ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; LACTIC ACID; REACTIVE OXYGEN METABOLITE;

ANAEROBIC GROWTH; ANIMAL; ENZYME IMMUNOASSAY; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; GLYCOLYSIS; LUNG TUMOR; METABOLISM; MITOCHONDRION; MOUSE; NUDE MOUSE; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; SECONDARY; SIGNAL TRANSDUCTION;

ANAEROBIOSIS; ANIMALS; FEMALE; GLUCOSE; GLYCOLYSIS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOENZYME TECHNIQUES; LACTIC ACID; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84899113715     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03793     Document Type: Article

References (36)

1. Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559-1564 (2011).
2. De Craene, B. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13, 97-110 (2013).
3. Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9, 265-273 (2009).
4. Egeblad, M.&Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2, 161-174 (2002).
5. Pantel, K., Brakenhoff, R. H.&Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8, 329-340 (2008).
6. Erler, J. T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35-44 (2009).
7. Erler, J. T. et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440, 1222-1226 (2006).
8. Psaila, B. & Lyden, D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9, 285-293 (2009).
9. Wang, G. L., Jiang, B. H., Rue, E. A.&Semenza, G. L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92, 5510-5514 (1995).
10. Kallio, P. J., Pongratz, I., Gradin, K., McGuire, J. & Poellinger, L. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci U S A 94, 5667-5672 (1997).
11. Jaakkola, P. et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468-472 (2001).
12. Forsythe, J. A. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16, 4604-4613 (1996).
13. Norris, M. L. & Millhorn, D. E. Hypoxia-induced protein binding to O2- responsive sequences on the tyrosine hydroxylase gene. J Biol Chem 270, 23774-23779 (1995).
14. Semenza, G. L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721-732 (2003).
15. Semenza, G. L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625-634 (2010).
16. Semenza, G. L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33, 207-214 (2012).
17. Semenza, G. L. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 19, 12-16 (2009).
18. Harada, H. & Hiraoka, M. Hypoxia-inducible factor 1 in tumor radioresistance. Curr Signal Transd Ther 5, 188-196 (2010).
19. Harada, H. et al. Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels. Nat Commun 3, 783 (2012).
20. Harada, H. et al. Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy. Br J Cancer 100, 747-757 (2009).
21. Harada, H. et al. Significance of HIF-1-active cells in angiogenesis and radioresistance. Oncogene 26, 7508-7516 (2007).
22. Yeom, C. J., Goto, Y., Zhu, Y., Hiraoka, M. & Harada, H. Microenvironments and cellular characteristics in the micro tumor cords of malignant solid tumors. Int J Mol Sci 13, 13949-13965 (2012).
23. Harada, H., Kizaka-Kondoh, S. & Hiraoka, M. Optical imaging of tumor hypoxia and evaluation of efficacy of a hypoxia-targeting drug in living animals. Mol Imaging 4, 182-193 (2005).
24. Sato, T. et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med 174, 530-537 (2006).
25. Nakamura, A. & Goto, S. Analysis of protein carbonyls with 2,4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis. J Biochem 119, 768-774 (1996).
26. Robinson, C. E. et al. Determination of protein carbonyl groups by immunoblotting. Anal Biochem 266, 48-57 (1999).
27. Ishimoto, T. et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19, 387-400 (2011).
28. Muller, M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 11, 59-98 (2009).
29. Murphy, M. P. et al.Unraveling the biological roles of reactive oxygen species. Cell Metab 13, 361-366 (2011).
30. Li, C. & Jackson, R. M. Reactive species mechanisms of cellular hypoxiareoxygenation injury. Am J Physiol Cell Physiol 282, C227-241 (2002).
31. Wang, W. et al. Superoxide flashes in single mitochondria. Cell 134, 279-290 (2008).
32. Zhou, T. B., Qin, Y. H., Lei, F. Y., Huang, W. F. & Drummen, G. P. Prohibitin is associated with antioxidative protection in hypoxia/reoxygenation-induced renal tubular epithelial cell injury. Sci Rep 3, 3123 (2013).
33. Harada, H. et al. The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors. J Biol Chem 284, 5332-5342 (2009).
34. Harada, H. et al. The combination of hypoxia-response enhancers and an oxygendependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts. Biochem Biophys Res Commun 360, 791-796 (2007).
35. Zeng, L. et al. TS-1 enhances the effect of radiotherapy by suppressing radiationinduced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis. Cancer Sci 99, 2327-2335 (2008).
36. Zhu, Y. et al. Involvement of decreased hypoxia-inducible factor 1 activity and resultant G1-S cell cycle transition in radioresistance of perinecrotic tumor cells. Oncogene 32, 2058-2068 (2013).